Autor: Stephane
Stephane ROCHE, PhD, HDR
CTO & Medical director Stephane Roche Researcher, Stéphane ROCHE holds a PhD in Biological and Medical Engineering and is a[…]
WeiterlesenQSM as an imaging biomarker for Alzheimer’s disease
Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations Yuto Uchida, Hirohito Kan, Keita Sakurai,[…]
WeiterlesenIhr Partner für Quantitative Susceptibility Mapping in Europa
Ihr Partner für Quantitative Susceptibility Mapping in Europa QSM ist ein innovatives, patentiertes Verfahren, das ursprünglich an der Cornell University[…]
WeiterlesenHow does QSM perform in detecting this process?
Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process? Farzaneh Nikparast,[…]
WeiterlesensAPP & Abeta in CSF
Correlations between soluble alpha/beta forms of amyloid precursor protein and Abeta38, 40 and 42 in human cerebrospinal fluid Audrey Gabelle,[…]
WeiterlesenFDA-clearance
510(k) Premarket Notification Device Classification Name system, nuclear magnetic resonance imaging 510(k) Number K210415 Device name QSM software, QSMetric Applicant[…]
WeiterlesenQSM Patent
Accurate quantification of magnetic susceptibility in molecular mri Inventor: Yi Wang, Ludovic De Rochefort, Bryan Kressler, Tian LIU, Pascal Spincemaille
Weiterlesen